Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

NCT02501902 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Pancreatic Ductal Adenocarcinoma

Interventions

DRUG: Palbociclib
DRUG: Nab-Paclitaxel

Sponsor

Pfizer

Collaborators

[object Object]